2nd Annual IBDHorizons Gulf Coast Symposium

IBDHorizons is pleased to announce the 2nd Annual IBD-focused Gulf Coast Symposium in Austin, in collaboration with GI Alliance

IBDHorizons provides free IBD conferences open to all those involved in the care of patients with IBD.

At our 2nd Annual Gulf Coast IBD Conference, you will learn from and engage in discourse about the latest in Inflammatory Bowel Disease (IBD) from world-renowned faculty, on Saturday, November 18, 2023.

During the IBDHorizons Gulf Coast Symposium, you’ll be provided with a smooth experience including catered meals, thoughtful breaks throughout the day’s events, and a personal tablet to engage with the presentations. We dedicate more time than most other IBD education conferences to our open panel discussions and real-world case studies to be examined alongside the faculty.

Our IBD conference will be hosted at the Hyatt Regency Austin, 208 Barton Springs Rd, Austin, Texas 78704 

 

CME/CE/CPE

This IBDHorizons event will be accredited for up to 6 CME, CE, and CPE credit hours for attendees. Submit your activity evaluation and application for CME form after attending the symposium.

Cost

Registration is required to plan accordingly, but registration for IBDHorizons Austin is complimentary to attendees!

Join us for this amazing IBD conference opportunity to engage with notable leaders in the field of Inflammatory Bowel Disease (IBD).

Exhibits

IBDHorizons IBD-dedicated conference presents an excellent opportunity for industry exhibits. Please contact us for more information.

Agenda

Please see hourly schedule below for topic list! As always, our IBD Founders and honorary board members Dr. Brian Feagan and Dr. Feza Remzi will be speaking.

Chairs

Dr. Tim Ritter and Dr. Harry Thomas

Topics

❏ 2023 IBD Treatment Options

❏ The Patient Specific Factors that Influence Outcomes in IBD

❏ Diagnostic Challenges in IBD

❏ Role of Imaging in IBD Today

❏ Women’s Health & IBD

❏ Guide to Discussing Surgery with IBD Patients

❏ Managing Complex IBD Patients Seeking a Second Opinion

❏ New and Developing IBD Pathways and Therapies

Endoscopy and Ultrasound Lab*

Due to popular request, IBDHorizons has added a live hands-on endoscopy lab session. Live lab session includes demonstrations and hands-on format allowing participants to review and try the newest endoscopic technology including:
  • Intestinal Ultrasound (IUS) for IBD
  • Full thickness resection devices
  • Endoscopic submucosal dissection
  • Virtual chromo-endoscopy
  • Standard endoscopic devices and technology
*If you have registered for the in-person Gulf Coast symposium, you will automatically be registered for this session.

 


Date

Nov 18 2023

Time

8:00 am - 3:30 pm

Location

Hyatt Regency Austin
208 Barton Springs Road Austin, TX 78704
Website
https://www.hyatt.com/en-US/hotel/texas/hyatt-regency-austin/ausra

Speakers

  • Anita Afzali, MD, MPH, MHCM
    Anita Afzali, MD, MPH, MHCM
    Professor of Medicine in the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine, Associate Chief Medical Officer of the UC Health System

    Dr. Anita Afzali is a Professor of Medicine in the Division of Digestive Diseases and Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine. She is also the Associate Chief Medical Officer of the UC Health System. She received her medical degree and then completed Internal Medicine residency and gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and graduated with a Masters in Public Health from The University of Washington. She then later obtained another Masters In Healthcare Management (MHCM) from Harvard T.H. Chan School of Public Health. Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty.

    While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of Gastroenterology Clinics. After Seattle, Dr. Afzali moved to Columbus, OH to be the Medical Director of The OSU IBD Center and the Vice Chair of Clinical Operations of Gastroenterology at The Ohio State University.

    Recently, she has transitioned to the University of Cincinnati where she serves as the Executive Vice Chair of the Department of Internal Medicine. Her research interests include drug study design, investigational drug trials, and clinical outcomes. She has extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several international advisory boards and committees including Chair of the American College of Gastroenterology (ACG) Educational Affairs Committee and Vice Chair of Publications Committee for the World Gastroenterology Organization (WGO).

  • Bincy Abraham, MD
    Bincy Abraham, MD
    Director, Fondren IBD Program, Director, Gastroenterology Fellowship Program Underwood Center for Digestive Disorders, Houston Methodist Hospital

    Bincy P Abraham, MD, MS, AGAF, FACG is the Distinguished Professor and Director of the Fondren Inflammatory Bowel Disease Program at the Underwood Digestive Diseases Center of Houston Methodist Hospital. She is also the Program Director for the Gastroenterology Fellowship at Houston Methodist Hospital.

    Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. After fellowship, she joined as faculty as assistant professor of medicine in the section of Gastroenterology and Hepatology at Baylor College of Medicine where she served as director of the Baylor Clinic Inflammatory Bowel Disease Center for over 5 years before her move to Houston Methodist Hospital. She is board-certified in Internal medicine and Gastroenterology.

    Her particular interest in inflammatory bowel disease includes the transition of adolescent IBD patients from pediatric to adult care as well as women’s issues and pregnancy in IBD. She chairs the Southern Regional Chapter of the CCFA Medical Advisory Committee, has served as president of the Texas Gulf Coast Gastroenterology Society, co-directed the Texas Society of Gastroenterology & Endoscopy Annual meeting, is involved in national committees for American College of Gastroenterology, and member of American Gastroenterology Association, and Crohn’s and Colitis Foundation.

  • Brian Feagan, MD, MSc
    Brian Feagan, MD, MSc
    Professor of Medicine at the Schulich School of Medicine & Dentistry in London, Ontario, Senior Scientific Director of Alimentiv Inc

    Dr. Brian Feagan is a gastroenterologist, with training in Clinical Epidemiology and Biostatistics. His research focus is the design, conduct, and execution of large-scale randomized controlled trials (RCTs) in Crohn’s disease (CD) and ulcerative colitis (UC), and over the past 30 years, has been Principal Investigator in over 140 multi-center RCTs. His research has been devoted to the development, validation, and optimization of outcome measures to assess the efficacy of novel therapeutics in CD and UC. Dr. Feagan is Professor of Medicine at the Schulich School of Medicine & Dentistry, a gastroenterologist at London Health Sciences Centre and Senior Scientific Director of Alimentiv Inc (formerly Robarts Clinical Trials Inc).

    Brian G. Feagan completed a medical degree at the University of Western Ontario in London, Ontario, Canada. His postdoctoral training included a residency in the Department of Medicine and a fellowship in Gastroenterology at the University of Western Ontario. A Fellow of the Royal College of Physicians and Surgeons of Canada, Dr. Feagan holds membership in the Canadian and American Association of Gastroenterology, the American College of Gastroenterology, the College of Physicians and Surgeons of Ontario, Crohn’s and Colitis Canada (CCC), and the European Crohn’s & Colitis Organization (ECCO). He is the recipient of the 2013 Senior Achievement Award from the Crohn’s & Colitis Foundation of America (CCF) and the Dean’s Award of Excellence in 2013 from the University of Western Ontario. He has authored over 200 articles, book chapters and has also given over 900 invited presentations, at national and international scientific meetings. In 1997, Dr. Feagan became Director of Robarts Clinical Trials (now Alimentiv, Inc.).

  • Feza Remzi, MD
    Feza Remzi, MD
    Vice President and Colorectal Surgeon at Northwell Health Center for Advanced IBD Care, New York

    Dr. Feza Remzi is the Vice President and a colorectal surgeon at the Center for Advanced IBD Care at Northwell Health in New York.

    He is a national and international expert in colorectal surgery, specializing in the surgical management of inflammatory bowel disease (IBD). He performs pelvic pouch surgery, complex abdominopelvic re-operative surgery, and sphincter-saving surgery for rectal cancer, utilizing minimally invasive techniques to manage colorectal conditions.

    Dr. Remzi resides in New York with his wife and son. They enjoy traveling and spending time together as a family.

    Dr. Remzi is an honorary IBDHorizons Board member.

    @FezaRemziMD

  • Gary Lichtenstein, MD
    Gary Lichtenstein, MD
    Director, Inflammatory Bowel Disease Center, Professor of Medicine, University of Pennsylvania

    Gary R. Lichtenstein, MD, FACP, FACG, AGAF is the Director of the Inflammatory Bowel Disease Center and a Professor of Medicine in the Gastrointestinal Division of the Department of Medicine at the Hospital of the University of Pennsylvania and the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania.

    Dr. Lichtenstein earned his medical degree from the Mount Sinai School of Medicine, in New York, New York. He then completed his internship and residency in Internal Medicine at Duke University Medical Center, in Durham, North Carolina. He also served a fellowship in Gastroenterology at the Hospital of the University of Pennsylvania of the University Of Pennsylvania School Of Medicine. His current research interests encompass investigational therapies for the treatment of ulcerative colitis and Crohn’s disease. Dr. Lichtenstein has received numerous research grants focusing on these areas and has served as the national/ international principal investigator evaluating novel agents for therapeutic trials in the treatment of Ulcerative Colitis and Crohn’s disease.

  • Ghassan Wahbeh, MD
    Ghassan Wahbeh, MD
    Director of the Inflammatory Bowel Disease (IBD) Center at Seattle Children’s Hospital. Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine and Director of Clinical Gastroenterology Operations.​

    Ghassan Wahbeh, MD, is the Director of the Inflammatory Bowel Disease (IBD) Center at Seattle Children’s Hospital. He is a Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine and Director of Clinical Gastroenterology Operations. Dr. Wahbeh’s clinical focus is in advanced care for children, adolescents, and young adults with Crohn’s Disease and ulcerative colitis, including advanced therapeutics and perioperative IBD management. He leads the Intestinal Ultrasound Program at Seattle Children’s.

    Dr. Wahbeh’s research interests include novel therapeutics for pediatric IBD, advanced disease monitoring towards mucosal healing, clinical standard work in managing severe colitis and complicated Crohn’s disease including fistulizing and stricturing phenotypes, and navigating IBD surgical options. 
He is actively involved in translational IBD research at Seattle Children’s Hospital. Dr. Wahbeh is actively involved as teaching faculty in medical student education, resident training and fellow physician specialty, and advanced IBD specialty training.

    He is the honored recipient of the Outstanding Teaching Faculty Award, as well as the Family Choice Award, and the Northwest Crohn’s & Colitis Foundation service award. Dr. Wahbeh enjoys playing soccer, skiing, and paddle-boarding with his wife and kids.

    Dr. Ghassan Wahbeh is a co-founder of IBDHorizons

    @PedsIBD_Wahbeh

  • Harry Thomas, MD
    Harry Thomas, MD
    Gastroenterologist, Site Principal Investigator for multiple IBD clinical trials at Austin Gastroenterology

    Harry J. Thomas, MD, graduated from the University of Cambridge with a bachelor’s degree in natural sciences and received a medical degree from the University of Oxford. In addition, he received a master’s degree in public health from the London School of Hygiene & Tropical Medicine. After serving as a house officer in the U.K. National Health Service, he completed his internship and residency in medicine and fellowship in gastroenterology at Massachusetts General Hospital and Harvard Medical School.

    He moved to Austin in 2014 and practiced at Baylor Scott & White where he was an assistant professor of medicine at Texas A&M prior to joining Austin Gastroenterology in 2017. His clinical interests are inflammatory bowel diseases (IBD) and he has served as Site Principal Investigator for multiple clinical trials in Crohn’s disease and ulcerative colitis. He is active with the Crohn’s & Colitis Foundation, serving as co-chair of the National Scientific Advisory Committee (NSAC) Patient Education committee, member of the Austin Leadership Board, and chair of the Austin Mission Committee. In addition, he serves on the Board of Directors of People’s Community Clinic, a Federally Qualified Health Center in Austin, and on the board of the Texas Society for Gastroenterology and Endoscopy and the Digestive Health Physicians Association. During the COVID-19 pandemic, he organized a group of over 100 local volunteer health care providers – Health Alliance for Vaccine Equity – to administer vaccinations to underserved populations in Austin-Travis County through pop-up clinics.

    Dr. Thomas lives in Austin with his wife and kids, and enjoys finding delicious foods and street fairs.

    @DrHarryThomas

  • Laura Raffals, MD, MS
    Laura Raffals, MD, MS
    Professor of Medicine, Department of Medicine Associate Chair of Faculty Development, Vice Chair of the Division of Gastroenterology and Hepatology, and Chair of the Operations Coordinating Group for the Mayo Clinic

    Laura Raffals, MD, MS is Professor of Medicine, Department of Medicine Associate Chair of Faculty Development, Vice Chair of the Division of Gastroenterology and Hepatology at Mayo Clinic, and Chair of the Operations Coordinating Group for the Rochester, MN campus of Mayo Clinic. Dr. Raffals’ clinical and research interests have focused on inflammatory bowel disease (IBD) with a focus on pouch disorders, exploring the intersection of pouch motility disorders, and pouch inflammation. Dr. Raffals is a speaker in faculty development, career development, and work-life integration.

    Dr. Raffals has two daughters, who keep her on her toes with all of their activities and shenanigans.

  • Scott D. Lee, MD
    Scott D. Lee, MD
    Associate Professor of Medicine, Director, Clinical Inflammatory Bowel Disease Program at University of Washington Medical Center

    Dr. Scott D. Lee is an Associate Professor of Medicine with expertise in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Dr. Lee earned his bachelor’s degree at Pomona College and his M.D. at Jefferson Medical College. He completed his residency in internal medicine at the University of Colorado in Denver. After residency, Dr. Lee completed his gastroenterology fellowship at the University of Washington. After completing his fellowship, he attended the University of Chicago and Cedar-Sinai in Los Angeles as a visiting physician to gain additional training in IBD. Since finishing his fellowship, he has been an attending gastroenterology physician at the University of Washington Medical Center. Currently, his clinical practice is at the Digestive Disease Center at the University of Washington and is dedicated exclusively to providing care to patients with the diagnosis of IBD. His research is focused on inflammatory bowel diseases (IBD) including – new therapies for IBD, improving outcomes in the treatment and long-term management of IBD, evaluation of non-invasive biomarkers to assess disease activity in IBD patients, and the effects of the microbiome on IBD. He has participated in more than 100 clinical trials in IBD and continues to have an active clinical research program. He is a member of the Crohn’s Colitis Foundation of America (CCF), American Gastroenterology Association, American College of Gastroenterology, and American Society of Gastrointestinal Endoscopy. He is a past chair of Northwest CCFA Chapter Medical Advisory Committee (CMAC) and continues as a current member of the CMAC.

  • Tim Ritter, MD, FASGE
    Tim Ritter, MD, FASGE
    Senior Medical Director of the Department of Research and Education at GI Alliance

    Dr. Timothy Ritter is Senior Medical Director of the Department of Research and Education at GI Alliance. His interest within GI is Inflammatory Bowel Disease and Clinical Trials.

    He is a practicing gastroenterologist in Southlake, Texas and an Assistant Professor of Medicine at TCU School of Medicine.

    Dr. Ritter earned his medical degree from the University of Texas Southwestern, where he also completed his residency and fellowship. He was awarded a Regional Top Doctor in 2014 by Castle Connolly and is a professional member of the American Gastroenterological Association, the American College of Gastroenterology, the Texas Society for Gastroenterology & Endoscopy, and the American Society for Gastrointestinal Endoscopy.

  • Tina Ha, MD
    Tina Ha, MD
    Director, Inflammatory Bowel Diseases Section, Mayo Clinic Arizona

    Dr. Tina Ha is a gastroenterologist in Scottsdale, Arizona. She is affiliated with multiple hospitals, including Mayo Clinic- Phoenix, where she is the Director of the Inflammatory Bowel Diseases Section, and Cedars-Sinai Medical Center.

    Dr. Ha earned her medical degree from the Albert Einstein College of Medicine of Yeshiva University. She did an internal medicine residency at Washington University in St. Louis School of Medicine as well as a fellowship in gastroenterology. She continued to a fellowship in inflammatory bowel disease at the Icahn School of Medicine at Mount Sinai.

    She likes to spend her free time exploring with her golden retriever Sebastian, – who does not enjoy walking or retrieving, friends and family.

    Dr. Ha has contributed to many publications on the topic of IBD.

QR Code

Leave a Reply

Your email address will not be published. Required fields are marked *

Thank you!

Success! We have received your activity evaluation and application for credit.

When can I expect my credit? Please allow 4-6 weeks from the date of the event for processing.

Who will I hear from? The Annenberg Center for Health Sciences at Eisenhower processes certificates and will email you once the certificate is issued.

Will they email my certificate directly? No, they will email you instructions to download the certificate from their site.

What do I do when the certificate is ready?

Your credit certificates will be stored on the website of our accrediting partner (annenberg.net)

  • Use this email from your evaluations, to create an account at Annenberg.net
  • If you already have an account, select Log In and reset your password
    • Once Logged in
      • Select Profile
      • Then proceed to My Courses
      • Go to Transcript and/or print your Certificate

REMINDER

Our team will not have copies of your certificates

Your certificates are linked to the email address provided on the evaluation forms.

Certificates are issued 4-6 weeks after an event

Your submission has been received!

We appreciate your submission into the Research Plenary Session at the 7th Annual IBDHorizons Pacific Northwest Symposium. The program committee looks forward to reviewing each submission carefully.  The team will notify about decisions by February 28, 2022 via email. Please check that you received a confirmation email.

For the winners, we are excited to hear your abstracts presented during the 7th Pacific Northwest Symposium on Saturday, March 5, 2022 at the Hyatt Regency Seattle. Further details will be provided by email. Thank you again and don’t forget to register!

Your submission has been received!

We appreciate your submission into the Research Plenary Session at the IBDHorizons Midwest Symposium. The program committee looks forward to reviewing each submission carefully.  The team will notify about decisions by January 31, 2024 via email. Please check that you received a confirmation email.

For the winners, we are excited to hear your abstracts presented during the 7th Midwest Symposium on Saturday, February 10, 2024 at the Hyatt Regency Cincinnati. Further details will be provided by email. Thank you again and don’t forget to register!